EMS Group tops Valor 1000 pharma ranking for sixth year, 2025 sales R$9.31B

EMS Group retained its position as the leading pharmaceutical and cosmetics company in Brazil's Valor 1000 ranking for the sixth consecutive year, with 2025 net sales of R$9.31 billion and a 26% share of the generics market. The company projects revenue growth in 2026, though specific targets were not disclosed. This is a routine corporate performance milestone with limited market-moving implications beyond sector-specific recognition.